Literature DB >> 20214518

Magnetic resonance imaging of nasopharyngeal carcinoma.

Eugene Yu1, Brian O'Sullivan, John Kim, Lillian Siu, Eric Bartlett.   

Abstract

Nasopharyngeal carcinoma (NPC) is a malignant tumor that its the highest rates in Southeast Asia. It is a locally aggressive neoplasm that has a propensity for developing regional neck adenopathy. The main treatment modality consists primarily of radiation therapy. Cross-sectional imaging is important in order to achieve an accurate delineation of tumor extent, thereby facilitating both staging and treatment. MRI is currently considered the best modality to assess for NPC. The aim of this review is to provide a pictorial MRI review of NPC according to the recently released 7th edition of the International Union Against Cancer staging system.

Entities:  

Mesh:

Year:  2010        PMID: 20214518     DOI: 10.1586/era.10.9

Source DB:  PubMed          Journal:  Expert Rev Anticancer Ther        ISSN: 1473-7140            Impact factor:   4.512


  10 in total

1.  Risk factors and prediction-score model for distant metastasis in nasopharyngeal carcinoma treated with intensity-modulated radiotherapy.

Authors:  An-Chuan Li; Wei-Wei Xiao; Lin Wang; Guan-Zhu Shen; An-An Xu; Yan-Qing Cao; Shao-Min Huang; Cheng-Guang Lin; Fei Han; Xiao-Wu Deng; Chong Zhao
Journal:  Tumour Biol       Date:  2015-05-27

2.  Pretreatment [18F]FDG PET/CT and MRI in the prognosis of nasopharyngeal carcinoma.

Authors:  Amina Gihbid; Ghofrane Cherkaoui Salhi; Imane El Alami; Hasnaa Belgadir; Nezha Tawfiq; Karima Bendahou; Mohammed El Mzibri; Rachida Cadi; Naima El Benna; Amal Guensi; Meriem Khyatti
Journal:  Ann Nucl Med       Date:  2022-07-14       Impact factor: 2.258

3.  Error in the parotid contour delineated using computed tomography images rather than magnetic resonance images during radiotherapy planning for nasopharyngeal carcinoma.

Authors:  Chengxin Liu; Xudong Kong; Guanzhong Gong; Tonghai Liu; Baosheng Li; Yong Yin
Journal:  Jpn J Radiol       Date:  2014-02-21       Impact factor: 2.374

Review 4.  Perineural Spread in Noncutaneous Head and Neck Cancer: New Insights into an Old Problem.

Authors:  Moran Amit; Ayelet Eran; Salem Billan; Eran Fridman; Shorook Na'ara; Tomer Charas; Ziv Gil
Journal:  J Neurol Surg B Skull Base       Date:  2016-02-26

5.  Can Parameters Other than Minimal Axial Diameter in MRI and PET/CT Further Improve Diagnostic Accuracy for Equivocal Retropharyngeal Lymph Nodes in Nasopharyngeal Carcinoma?

Authors:  Yu-Wen Wang; Chin-Shun Wu; Guo-Yi Zhang; Chih-Han Chang; Kuo-Sheng Cheng; Wei-Jen Yao; Yu-Kang Chang; Tsair-Wei Chien; Li-Ching Lin; Keng-Ren Lin
Journal:  PLoS One       Date:  2016-10-13       Impact factor: 3.240

6.  Prognostic value of total tumor volume in patients with nasopharyngeal carcinoma treated with intensity-modulated radiotherapy.

Authors:  Shao-Bo Liang; Jian-Jian Teng; Xue-Feng Hu; Xing-Li Yang; Min Luo; Xiao-Na Fang; Dong-Sheng Liu; Yong Chen; Li-Wu Fu
Journal:  BMC Cancer       Date:  2017-07-28       Impact factor: 4.430

7.  Arterial spin labeling and diffusion-weighted imaging for identification of retropharyngeal lymph nodes in patients with nasopharyngeal carcinoma.

Authors:  Xiaoduo Yu; Fan Yang; Xue Liu; Yanfeng Zhao; Yujie Li; Meng Lin; Lizhi Xie; Yuqing Shang
Journal:  Cancer Imaging       Date:  2022-08-17       Impact factor: 5.605

Review 8.  Emerging treatment options for nasopharyngeal carcinoma.

Authors:  Lu Zhang; Qiu-Yan Chen; Huai Liu; Lin-Quan Tang; Hai-Qiang Mai
Journal:  Drug Des Devel Ther       Date:  2013-02-01       Impact factor: 4.162

9.  Verification of the Efficacy of New Diagnostic Criteria for Retropharyngeal Nodes in a Cohort of Nasopharyngeal Carcinoma Patients.

Authors:  Dom-Gene Tu; Hsuan-Yu Chen; Wei-Jen Yao; Yu-Sheng Hung; Yu-Kang Chang; Chih-Han Chang; Yu-Wen Wang
Journal:  Int J Med Sci       Date:  2021-08-13       Impact factor: 3.738

10.  The Chinese Society of Clinical Oncology (CSCO) clinical guidelines for the diagnosis and treatment of nasopharyngeal carcinoma.

Authors:  Ling-Long Tang; Yu-Pei Chen; Chuan-Ben Chen; Ming-Yuan Chen; Nian-Yong Chen; Xiao-Zhong Chen; Xiao-Jing Du; Wen-Feng Fang; Mei Feng; Jin Gao; Fei Han; Xia He; Chao-Su Hu; De-Sheng Hu; Guang-Yuan Hu; Hao Jiang; Wei Jiang; Feng Jin; Jin-Yi Lang; Jin-Gao Li; Shao-Jun Lin; Xu Liu; Qiu-Fang Liu; Lin Ma; Hai-Qiang Mai; Ji-Yong Qin; Liang-Fang Shen; Ying Sun; Pei-Guo Wang; Ren-Sheng Wang; Ruo-Zheng Wang; Xiao-Shen Wang; Ying Wang; Hui Wu; Yun-Fei Xia; Shao-Wen Xiao; Kun-Yu Yang; Jun-Lin Yi; Xiao-Dong Zhu; Jun Ma
Journal:  Cancer Commun (Lond)       Date:  2021-10-26
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.